BridgeMD
New treatment option for Dysphagia
Official title Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model in Head and Neck Cancer
ClinicalTrials.gov ID: NCT05621889
What this study is testing
- What it's testing
- This project aims to study an innovative intervention, the eG2 Intervention, developed by speech-language pathologists at the Centre hospitalier de l'Université de Montréal to improve therapeutic adherence and prevent dysphagia in patients treated with chemoradiotherapy for head and neck cancer. The innovation consists in offering a speech therapy intervention that is 1) virtual, 2) group-based (whereas it is usually individual) and 3) involves a patient partner.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults ≥ 18 years of age with a diagnosis of head or neck cancer
- Chemoradiotherapy treatments planned for curative purposes
- Planned external radiation therapy dose of at least ≥60 Grays
- Sufficient proficiency in French to complete self-reported questionnaires
You likely can't join if
- Remote metastases
- Previous or planned total laryngectomy
- Previous moderate/severe dysphagia known and/or evaluated by speech therapy
- Diagnosis of a second synchronous cancer at the time of study enrollment
- History of prior radiation therapy to the head and neck area
- Have a cognitive impairment (diagnosed or suspected) that may significantly interfere with participation in the intervention and various measurement...
The study team makes the final eligibility decision.
Where it's taking place
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montreal, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.